SCHEMBL7998906

SCHEMBL7998906

[CH2]c1sccc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3715393 0.71 CES1 (0.39)
SCHEMBL225071 0.71
Hydrochloric Acid SCHEMBL6193713 0.69
SCHEMBL20273158 0.69
SCHEMBL8007927 0.67
SCHEMBL8287305 0.67
SCHEMBL1097945 0.67
SCHEMBL2550983 0.67
SCHEMBL847407 0.67
SCHEMBL289053 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3987040-A 3-SUBSTITUTED METHYL-7-ACYLAMINO-7-METHOXY-2-CEPHEM-4-CARBOXYLIC ACID AND ITS ESTERS MERCK & CO., INC. (US) 1976-10-19 US claimed
CN-105593232-B Benzoxazoloxazinone compounds as coagulation factor Xa inhibitors 华北制药集团新药研究开发有限责任公司 2018-06-26 CN disclosed
CN-108069957-A Prolyl hydroxylase inhibitors and application thereof 广东东阳光药业有限公司 2018-05-25 CN disclosed
CN-105218560-B The synthesis technique of the chlorothiophene of 7 bromine 4 simultaneously [3,2 D] pyrimidine 上海泰坦科技股份有限公司 2017-09-29 CN disclosed
CN-105593232-A Benzoxazoloxazinone compounds as coagulation factor Xa inhibitors NORTH CHINA PHARMACEUTICAL NEW DRUG R & D CO LTD 2016-05-18 CN disclosed
CN-102786482-A Akt protein kinase inhibitors ARRAY BIOPHARMA INC 2012-11-21 CN disclosed
CN-101687883-B Modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMA CO LTD 2012-05-23 CN disclosed
CN-1212861-C Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing NF-K B inhibitors as the active ingredient DAIICHI SUNTORY PHARMACEATICAL (JP) 2005-08-03 CN disclosed
CN-1335777-A Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing NF-K B inhibitors as the active ingredient SUNTORY LTD (JP) 2002-02-13 CN disclosed
CN-1070192-C Thipyridines for use in control of helicobacter bacteria BYK GULDEN LOMBERG CHEM FAB (DE) 2001-08-29 CN disclosed
EP-0683776-A1 SUBSTITUTED HETEROARYLALKYLTHIOPYRIDINES FOR CONTROLLING HELICOBACTER BACTERIA Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1995-11-29 EP disclosed
WO-1994019346-A1 SUBSTITUTED HETEROARYLALKYLTHIOPYRIDINES FOR CONTROLLING HELICOBACTER BACTERIA BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1994-09-01 WO disclosed
EP-0034924-B1 PROCESS FOR PREPARING 3-IODOMETHYL CEPHALOSPORINS ELI LILLY AND COMPANY (US) 1984-07-04 EP disclosed
EP-0034924-A2 Process for preparing 3-iodomethyl cephalosporins ELI LILLY AND COMPANY (US) 1981-09-02 EP disclosed
US-4266049-A Process for 3-iodomethyl cephalosporins ELI LILLY AND COMPANY (US) 1981-05-05 US disclosed
US-4154845-A ANTIBIOTIC, BACTERICIDE MERCK & CO., INC. (US) 1979-05-15 US disclosed
US-4071529-A Derivatives of 6-aminopenicillanic acid MERCK & CO., INC. (US) 1978-01-31 US disclosed
US-4035359-A 6α, β-Substituted penicillin derivatives MERCK & CO., INC. (US) 1977-07-12 US disclosed
US-4008231-A Preparation of 3-methoxymethylcephalosporins ELI LILLY AND COMPANY (US) 1977-02-15 US disclosed
US-3987040-A 3-SUBSTITUTED METHYL-7-ACYLAMINO-7-METHOXY-2-CEPHEM-4-CARBOXYLIC ACID AND ITS ESTERS MERCK & CO., INC. (US) 1976-10-19 US disclosed